Literature DB >> 19662360

Microarray study of mechanism of trichostatin a inducing apoptosis of Molt-4 cells.

Zhenya Hong1, Zhiqiang Han, Min Xiao, Yang Yang, Xi Xia, Jianfeng Zhou.   

Abstract

Histone deacetylase was overexpressed in a variety of cancers and was closely correlated with oncogenic factors. The histone deacetylase inhibitor, trichostatin A (TSA) was shown to induce apoptosis in many cancer cells. However, the mechanism of TSA on induction of cancer cells apoptosis is poorly understood. This study was designed to characterize the global gene expression profiles before and after treatment of human leukemia cell line Molt-4 with TSA. Flow cytometry, MTT and DNA ladder were used to observe the effect of TSA on the apoptosis of MOLT-4 cells and normal human peripheral blood mononuclear cells (PBMC). Microarray, reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting were used to detect the difference of gene and protein expressions of Molt-4 cells after incubation of the cells with TSA. The results showed that TSA could induce Molt-4 apoptosis in dose- and time-dependent manners but spared PBMCs. Microarray analysis showed that after incubation with TSA for 9 h, 310 genes were upregulated and 313 genes were deregulated. These genes regulate the growth, differentiation and survival of cells. Among these genes, STAT5A was down-regulated by 80.4% and MYC was down-regulated by 77.3%. It was concluded that TSA has definite growth-inhibiting and apoptosis-inducing effects on Molt-4 cells in time- and dose-dependent manners, with weak cytotoxic effects on PBMCs at the same time. The mechanism of TSA selectively inducing apoptosis and inhibiting growth may be ascribed to the changes of pro-proliferation genes and anti-apoptosis genes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19662360     DOI: 10.1007/s11596-009-0411-y

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  26 in total

Review 1.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.

Authors:  Saverio Minucci; Pier Giuseppe Pelicci
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

2.  Myc inhibits p27-induced erythroid differentiation of leukemia cells by repressing erythroid master genes without reversing p27-mediated cell cycle arrest.

Authors:  Juan C Acosta; Nuria Ferrándiz; Gabriel Bretones; Verónica Torrano; Rosa Blanco; Carlos Richard; Brenda O'Connell; John Sedivy; M Dolores Delgado; Javier León
Journal:  Mol Cell Biol       Date:  2008-10-06       Impact factor: 4.272

3.  Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade.

Authors:  Noria Harir; Cédric Boudot; Katrin Friedbichler; Karoline Sonneck; Rudin Kondo; Séverine Martin-Lannerée; Lukas Kenner; Marc Kerenyi; Saliha Yahiaoui; Valérie Gouilleux-Gruart; Jean Gondry; Laurence Bénit; Isabelle Dusanter-Fourt; Kaïss Lassoued; Peter Valent; Richard Moriggl; Fabrice Gouilleux
Journal:  Blood       Date:  2008-06-25       Impact factor: 22.113

Review 4.  STATs: signal transducers and activators of transcription.

Authors:  J N Ihle
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

5.  Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells. Microarray analysis reveals defective induction of p53 target genes and upregulation of chaperone genes.

Authors:  Eva Ceballos; Maria J Muñoz-Alonso; Bernd Berwanger; Juan C Acosta; Rafael Hernández; Michael Krause; Oliver Hartmann; Martin Eilers; Javier León
Journal:  Oncogene       Date:  2005-06-30       Impact factor: 9.867

Review 6.  Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B.

Authors:  Lothar Hennighausen; Gertraud W Robinson
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

7.  [Effect of trichostatin A on histone acetylation level and apoptosis in HL-60 cells].

Authors:  Wei-Kai Chen; Yan Chen; Jun-Xia Gu; Guo-Hui Cui
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2004-06

8.  Histone deacetylase 5 represses the transcription of cyclin D3.

Authors:  Sangita Roy; Audrey C Shor; Tapan K Bagui; Edward Seto; W Jackson Pledger
Journal:  J Cell Biochem       Date:  2008-08-15       Impact factor: 4.429

9.  Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model.

Authors:  Akihiko Miyanaga; Akihiko Gemma; Rintaro Noro; Kiyoko Kataoka; Kuniko Matsuda; Michiya Nara; Tetsuya Okano; Masahiro Seike; Akinobu Yoshimura; Akiko Kawakami; Haruka Uesaka; Hiroki Nakae; Shoji Kudoh
Journal:  Mol Cancer Ther       Date:  2008-07-07       Impact factor: 6.261

10.  Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation.

Authors:  Zhaoliang Li; David Boone; Stephen R Hann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

View more
  2 in total

1.  In vitro inhibitory effect of trichostatin A on canine grade 3 mast cell tumor.

Authors:  Marcia Kazumi Nagamine; Daniel S Sanches; Katia C Pinello; Luciana Neves Torres; Gregory Mennecier; Andréia O Latorre; Heidge Fukumasu; Maria Lucia Zaidan Dagli
Journal:  Vet Res Commun       Date:  2011-04-07       Impact factor: 2.459

2.  Epigenetic Regulation via Altered Histone Acetylation Results in Suppression of Mast Cell Function and Mast Cell-Mediated Food Allergic Responses.

Authors:  Dylan Krajewski; Edwin Kaczenski; Jeffrey Rovatti; Stephanie Polukort; Chelsea Thompson; Catherine Dollard; Jennifer Ser-Dolansky; Sallie S Schneider; Shannon R M Kinney; Clinton B Mathias
Journal:  Front Immunol       Date:  2018-10-23       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.